143 related articles for article (PubMed ID: 7295401)
21. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men.
Pivac N; Knezevic J; Mustapic M; Dezeljin M; Muck-Seler D; Kozaric-Kovacic D; Balija M; Matijevic T; Pavelic J
Life Sci; 2006 May; 79(1):45-9. PubMed ID: 16427095
[TBL] [Abstract][Full Text] [Related]
22. Intracellular distribution of monoamine oxidase, 5-hydroxytryptamine and histamine in blood platelets of rabbit.
Solatunturi E; Paasonen MK
Ann Med Exp Biol Fenn; 1966; 44(3):427-30. PubMed ID: 5958861
[No Abstract] [Full Text] [Related]
23. Neuropsychological function and platelet monoamine oxidase activity levels in type I alcoholic patients.
Pombo S; Levy P; Bicho M; Ismail F; Cardoso JM
Alcohol Alcohol; 2008; 43(4):423-30. PubMed ID: 18408241
[TBL] [Abstract][Full Text] [Related]
24. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes.
Devor EJ; Cloninger CR; Hoffman PL; Tabakoff B
Am J Med Genet; 1993 Dec; 48(4):209-13. PubMed ID: 8135303
[TBL] [Abstract][Full Text] [Related]
25. Association of 5-HTT gene polymorphism, platelet MAO activity, and drive for thinness in a population-based sample of adolescent girls.
Akkermann K; Paaver M; Nordquist N; Oreland L; Harro J
Int J Eat Disord; 2008 Jul; 41(5):399-404. PubMed ID: 18306344
[TBL] [Abstract][Full Text] [Related]
26. Type B monoamine oxidase activity in human brain malignant tumors.
Marcozzi G; Befani O; Mondovì B
Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212
[TBL] [Abstract][Full Text] [Related]
27. Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.
Berggren U; Eriksson M; Fahlke C; Blennow K; Balldin J
Alcohol Alcohol; 2007; 42(3):267-71. PubMed ID: 17526638
[TBL] [Abstract][Full Text] [Related]
28. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
[TBL] [Abstract][Full Text] [Related]
29. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
Sallinen V; Sundvik M; Reenilä I; Peitsaro N; Khrustalyov D; Anichtchik O; Toleikyte G; Kaslin J; Panula P
J Neurochem; 2009 Apr; 109(2):403-15. PubMed ID: 19222706
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of platelet histamine and serotonin with their corresponding plasma oxidases in asthmatics with normals.
Matkar NM; Rupwate RU; Desai NK; Kamat SR
J Assoc Physicians India; 1999 Sep; 47(9):878-82. PubMed ID: 10778656
[TBL] [Abstract][Full Text] [Related]
31. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
[TBL] [Abstract][Full Text] [Related]
32. [Serotonin and autism].
Kamoun P; Douay O
Ann Biol Clin (Paris); 1980; 38(4):201-5. PubMed ID: 6160783
[No Abstract] [Full Text] [Related]
33. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury.
Bianchi P; Kunduzova O; Masini E; Cambon C; Bani D; Raimondi L; Seguelas MH; Nistri S; Colucci W; Leducq N; Parini A
Circulation; 2005 Nov; 112(21):3297-305. PubMed ID: 16286591
[TBL] [Abstract][Full Text] [Related]
34. [Platelet monoamine oxidase activity in some neurological diseases of childhood].
Stagni S; Illuminati B; Mello P; Gualandi S; Scanabissi E
Boll Soc Ital Biol Sper; 1981 Jun; 57(12):1305-10. PubMed ID: 7295402
[TBL] [Abstract][Full Text] [Related]
35. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome.
Ashby CR; Carr LA; Cook CL; Steptoe MM; Franks DD
Biol Psychiatry; 1988 Jun; 24(2):225-33. PubMed ID: 3390499
[TBL] [Abstract][Full Text] [Related]
36. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
Pivac N; Mück-Seler D; Sagud M; Jakovljević M; Mustapić M; Mihaljević-Peles A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):759-65. PubMed ID: 12921906
[TBL] [Abstract][Full Text] [Related]
37. Serotonergic platelet markers of suicidal behavior--do they really exist?
Müller-Oerlinghausen B; Roggenbach J; Franke L
J Affect Disord; 2004 Apr; 79(1-3):13-24. PubMed ID: 15023476
[TBL] [Abstract][Full Text] [Related]
38. Platelet monoamine oxidase activity in underweight and weight-recovered females with anorexia nervosa.
Ehrlich S; Franke L; Schott R; Salbach-Andrae H; Pfeiffer E; Lehmkuhl U; Uebelhack R
Pharmacopsychiatry; 2008 Nov; 41(6):226-31. PubMed ID: 19067259
[TBL] [Abstract][Full Text] [Related]
39. Decreased platelet monoamine oxidase activity in female anorexia nervosa.
Díaz-Marsá M; Carrasco JL; Hollander E; César J; Saiz-Ruiz J
Acta Psychiatr Scand; 2000 Mar; 101(3):226-30. PubMed ID: 10721871
[TBL] [Abstract][Full Text] [Related]
40. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.
Lenders JW; Eisenhofer G; Abeling NG; Berger W; Murphy DL; Konings CH; Wagemakers LM; Kopin IJ; Karoum F; van Gennip AH; Brunner HG
J Clin Invest; 1996 Feb; 97(4):1010-9. PubMed ID: 8613523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
